Cited by

• Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe--a Hungarian nationwide observational study.

  Miheller P, Lakatos PL, Horváth G, Molnár T, Szamosi T, Czeglédi Z, Salamon A, Czimmer J, Rumi G, Palatka K, Papp M, Jakab Z, Szabó A, Gelley A, Lakatos L, Barta Z, Balázs C, Rácz I, Zeher M, Döbrönte Z, Altorjay I, Hunyady B, Simon L, Papp J, Banai J, Nagy F, Lonovics J, Ujszászy L, Muzes G, Herszényi L, Tulassay Z. Miheller P, et al. BMC Gastroenterol. 2009 Sep 10;9:66. doi: 10.1186/1471-230X-9-66. BMC Gastroenterol. 2009. PMID: 19740450 Free PMC article.
• Cutaneous Crohn's disease after proctocolectomy for medically refractory colonic Crohn's disease: a case series and review of the literature.

  Naffouj S, Marrero-Rivera GE, Nordenstam J, Amber KT, Trivedi I. Naffouj S, et al. Ann Gastroenterol. 2023 Jul-Aug;36(4):466-476. doi: 10.20524/aog.2023.0811. Epub 2023 May 30. Ann Gastroenterol. 2023. PMID: 37396002 Free PMC article.
• Management of cutaneous disorders related to inflammatory bowel disease.

  Pellicer Z, Santiago JM, Rodriguez A, Alonso V, Antón R, Bosca MM. Pellicer Z, et al. Ann Gastroenterol. 2012;25(1):21-26. Ann Gastroenterol. 2012. PMID: 24713996 Free PMC article. Review.
• Infliximab in the treatment of Crohn's disease.

  Poggioli G, Laureti S, Campieri M, Pierangeli F, Gionchetti P, Ugolini F, Gentilini L, Bazzi P, Rizzello F, Coscia M. Poggioli G, et al. Ther Clin Risk Manag. 2007 Jun;3(2):301-8. doi: 10.2147/tcrm.2007.3.2.301. Ther Clin Risk Manag. 2007. PMID: 18360638 Free PMC article.
• Metastatic Crohn's disease of external genitalia.

  Panackel C, John J, Krishnadas D, Vinayakumar KR. Panackel C, et al. Indian J Dermatol. 2008;53(3):146-8. doi: 10.4103/0019-5154.43207. Indian J Dermatol. 2008. PMID: 19882017 Free PMC article.